novo glp 1 With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins Novo Nordisk plans to slash

Morin: A comprehensive review on its versatile biological activity and associated therapeutic potential in treating cancers

10.1017/S0007114518000132 165

Front Immunol 16:1571247 Addissouky TA (2025) Beyond insulin: advancing frontiers in cell-based and genetic therapies for type 1 diabetes management

(s thay i trng sng mt khong 6 thng 2 nm)

MASLD is estimated to affect over 30% of the worldwide population, with prevalence rates exceeding 70% in individuals with T2DM, underscoring the severity of this metabolic-hepatic nexus (Garg and Zein, 2025)

Acute schistosomiasis is seen among individuals without previous parasitic exposure and presents as debilitating febrile illness at six to eight weeks post infection